Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.78

-0.64

-0.51

-0.37

Details

Expected EPS

-0.618961

Actual EPS

-0.54

Surprise EPS

0.08

Surprise Percent

+12.76%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.54 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.